Navigation Links
EntreMed in Medical Technology

Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients

... antitumor activity in preclinical models. entremed Vice President and Chief Medical Officer, Carolyn ...e pathology of hematological cancers. About entremed EntreMed, Inc. is a clinical-stage pharmaceutic...heumatoid arthritis. Additional information about entremed is available on the Company's web site at www.en...

EntreMed Presents Initial Clinical Results for ENMD-2076

...based chemotherapy in breast cancer. In addition, entremed has received an Orphan Drug Designation from the F...g candidate, a No Objection Letter was received by entremed from Health Canada permitting ENMD-2076 to be used...ther expand the clinical development of ENMD-2076, entremed has received a No Objection Letter (NOL) from the ...

EntreMed Receives New Patent for 2-Methoxyestradiol Analogs

...s of 2- methoxyestradiol (2ME2). The patent grants entremed composition-of-matter and method of use intellectu...MDLOGO ) Analogs of 2ME2 have been developed by entremed to improve metabolic stability and retain or enhan...s owned exclusively by EntreMed. James S. Burns, entremed President & Chief Executive Officer, commented, "T...

EntreMed Presents MKC-1 Phase 2 Data at American Society of Clinical Oncology Annual Meeting

...taxel-resistant models. To date, MKC-1 has been evaluated in over 400 patients in multiple Phase 1 and 2 clinical trials. Carolyn F. Sidor, MD, MBA, entremed Vice President and Chief Medical Officer commented on the results, "Although we did not meet our overall goal for this study, we are encouraged by the...

EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting

...n/prnh/20010620/ENMDLOGO ) Mark R. Bray, Ph.D., entremed Vice President, Research, will give an oral presen...the special session, "New Drugs on the Horizon 2." entremed will share the podium with representatives from le...ies without cardiovascular effects. In addition, entremed scientists are scheduled for the following poster ...

EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program

...ogical cancers later this year." James S. Burns, entremed President & Chief Executive Officer commented, "EN... Phase 1 study will trigger a milestone payment by entremed pursuant to EntreMed's acquisition of Miikana Ther... Miikana stockholders, either in cash or shares of entremed common stock. About EntreMed EntreMed, Inc. is...

EntreMed Commences Continuous Dosing Clinical Trial For MKC-1

...effect with novel molecular imaging techniques," commented Dr. Glenn Liu. entremed Vice President and Chief Medical Officer, Carolyn F. Sidor, M.D., M.B.A., c... other diseases, such as rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://www.entremed.com and in ...

EntreMed to Present at The New York Society of Security Analysts Industry Conference

...egulation and inflammation - processes vital to the treatment of cancer and other diseases, such as rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://www.entremed.com and in various filings with the Securities and Exchange Commission. CONTACT: ...

EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer

... of the cell cycle, and induce apoptosis. Carolyn F. Sidor, M.D., M.B.A., entremed Vice President and Chief Medical Officer, commented on the study, "Pancreat... other diseases, such as rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://www.entremed.com and in ...

EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model

...survival in cancer patients. Mark R. Bray, Ph.D., entremed Vice President, Research, commented on the results...ot a registered trademark of EntreMed, Inc. About entremed EntreMed, Inc. is a clinical-stage pharmaceutical...rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://...

EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198

...s overall antitumor effects. Mark R. Bray, Ph.D., entremed Vice President, Research, commented on the results...ny's web site at http://www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutical...rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://...

EntreMed Raises $20 Million to Support Clinical Development Program

...less fees, was funded at closing. James S. Burns, entremed President and Chief Executive Officer, commented on the financing, "This transaction provides entremed with a non-dilutive financing vehicle that strengt...Aurora-angiogenesis inhibitor in oncology." About entremed EntreMed, Inc. is a clinical-stage pharmaceutical...

EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer

...ic breast cancer (MBC). The data were presented by entremed collaborators during the 2007 Breast Cancer Sympos...ny's web site at http://www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutical...rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://...

EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds

...rapeutic agents. Carolyn F. Sidor, M.D., M.B.A., entremed Vice President and Chief Medical Officer, commente...w.entremed.com/">http://www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutica...rheumatoid arthritis. Additional information about entremed is available on the Company's website at

EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in Preclinical Models

...in inhibitor compounds. The data were presented by entremed scientists at the American Association for Cancer ... identification. Carolyn F. Sidor, M.D., M.B.A., entremed Vice President and Chief Medical Officer, stated, ...quence, leading to cell death (apoptosis). About entremed EntreMed, Inc. is a clinical-stage pharmaceutica...

EntreMed Presents Multi-Mechanism Results for ENMD-1198 at AACR Annual Meeting

...t candidate, ENMD-1198. The data were presented by entremed scientists and collaborators during two separate s...w.entremed.com/">http://www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutica...rheumatoid arthritis. Additional information about entremed is available on the Company's website at

EntreMed Presents Preclinical Data for MKC-1 in Hematological Cancers

...target="_blank" href= "http://www.entremed.com/">www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutical company developing ther... other diseases, such as rheumatoid arthritis. Additional information about entremed is available on the Company's website at http://www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutical company developing ther... other diseases, such as rheumatoid arthritis. Additional information about entremed is available on the Company's web site at entremed Vice President and Chief Medical Officer, commente...s a registered trademark of EntreMed, Inc. About entremed EntreMed, Inc. is a clinical-stage pharmaceutica...rheumatoid arthritis. Additional information about entremed is available on the Company's web site at

Clinical Results From EntreMed's Panzem NCD and Taxol Breast Cancer Study Presented at ASCO

...anisms of action. Carolyn F. Sidor, M.D., M.B.A, entremed Vice President and Chief Medical Officer, commente...enefit from treatment with Panzem(R) NCD." About entremed EntreMed, Inc. is a clinical-stage pharmaceutica...rheumatoid arthritis. Additional information about entremed is available on the Company's website at
Other Tags
(Date:8/27/2014)... CHICAGO , Aug. 27, 2014 /PRNewswire-iReach/ -- The ... hosting the 36 th Annual International Conference (EMBC,14), ... and Towers in Chicago, Illinois , ... than 2,500 global leaders, students, and industry professionals in ... Logo - http://photos.prnewswire.com/prnh/20140827/140333 ...
(Date:8/27/2014)... But every creature is a baby once. , A ... 24 very young dinosaurs and one older individual is ... caretaker, according to a new study by University of ... Dodson led the work, collaborating with researchers from China,s ... held. Hedrick is a doctoral student in the School ...
(Date:8/27/2014)... is available in German . ... the most common inherited disease affecting the peripheral nervous ... Max Planck Institute of Experimental Medicine and University Medical ... cells is impaired in rats with the disease. These ... known as myelin, which facilitates the rapid transfer of ...
Breaking Biology News(10 mins):Global Leaders In Science, Medicine, And Engineering Gather For The 36th Annual International Conference Of The IEEE Engineering In Medicine And Biology Society, August 26-30 In Chicago 2Global Leaders In Science, Medicine, And Engineering Gather For The 36th Annual International Conference Of The IEEE Engineering In Medicine And Biology Society, August 26-30 In Chicago 3Penn paleontologists describe a possible dinosaur nest and young 'babysitter' 2Penn paleontologists describe a possible dinosaur nest and young 'babysitter' 3Potential therapy for incurable Charcot-Marie-Tooth disease 2
(Date:8/27/2014)... Jaha was founded with a vision that fitness is ... industry’s most affordable fitness tracker together with an app to ... Jaha plans to announce their latest concept, an ... locate, challenge and motivate. , The Jaha Kickstarter ... support and to raise awareness on this new concept for ...
(Date:8/27/2014)... Representatives with Recharge Retreats announced ... of destinations for International Yoga Teacher Trainings. , Chris ... the company chose Italy due to the fact that ... since it's an easy flight for Canadians and Americans, ... all over Europe, UK, Africa, and the Middle East. ...
(Date:8/27/2014)... 27, 2014 Cash House 's contributions ... the overall upkeep of the shelter including new initiatives and ... to change the lives of each youth who walk through ... emergency shelter for youth ages 16-25. Not only does Horizons ... and resources for the youth who come through their doors. ...
(Date:8/27/2014)... 2014 Nava Beauty Store and Spa aims ... patrons from those seeking luxury care products to the everyday ... high end luxurious brands like Valmont and Elemis to cater ... brands like Dermalogica and Bliss to provide easy to use ... also offer purely organic skin care products such as Jurlique, ...
(Date:8/27/2014)... August 27, 2014 The Global and ... study on the current state of the Maleic Anhydride ... a basic overview of the industry, including definitions, applications ... domestic market analysis are provided with a focus on ... A comparison between the international and Chinese situation is ...
Breaking Medicine News(10 mins):Health News:Jaha, Inc. The Most Affordable Fitness Band in the Market Released on Kickstarter 2Health News:Recharge Retreats Adds Italy to Its International Yoga Teacher Trainings Destinations 2Health News:Recharge Retreats Adds Italy to Its International Yoga Teacher Trainings Destinations 3Health News:Cash House a Major Supporter of Horizons for Youth 2Health News:Cash House a Major Supporter of Horizons for Youth 3Health News:Nava Beauty Store Announce Grand Opening in Great Neck, New York 2Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 2Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 3Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 4Health News:Maleic Anhydride Industry & Isoprene Market Global and China Analysis Now Available at ReportsnReports.com 5
Other Contents